Tapewire

Nasdaq · USD

FDMT

4D Molecular Therapeutics, Inc.

Export transactions ↓
Tapewire entity
2419
SEC CIK
0001650648
Parsed reports
169

Last 12 months

Inside the activity.

0 purchase rows · 24 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202600
Feb 202600
Mar 202602
Apr 202600
May 202600
Jun 202604
Jul 202603
Aug 202606
Sep 202603
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 01, 2022 Filed Dec 5, 2022 22:33 UTC
Bizily ScottChief Legal and HR Officer
SaleCommon Stock 1,000 $21.78 $21,775.00
Disclosure

SEC source: 0001567619-22-021291 · doc1.xml · nonDerivative · entry 7

Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,607

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The transaction was executed in multiple trades in prices ranging from $21.21 to $22.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 22:33 UTC
Bizily ScottChief Legal and HR Officer
Exercise / conversionCommon Stock 3,750 $8.04 $30,150.00
Disclosure

SEC source: 0001567619-22-021291 · doc1.xml · nonDerivative · entry 6

Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,607

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 22:33 UTC
Bizily ScottChief Legal and HR Officer
SaleCommon Stock 100 $24.49 $2,449.00
Disclosure

SEC source: 0001567619-22-021291 · doc1.xml · nonDerivative · entry 5

Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,857

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 22:33 UTC
Bizily ScottChief Legal and HR Officer
SaleCommon Stock 400 $23.25 $9,300.00
Disclosure

SEC source: 0001567619-22-021291 · doc1.xml · nonDerivative · entry 4

Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,957

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The transaction was executed in multiple trades in prices ranging from $23.16 to $23.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 22:33 UTC
Bizily ScottChief Legal and HR Officer
SaleCommon Stock 975 $22.71 $22,147.03
Disclosure

SEC source: 0001567619-22-021291 · doc1.xml · nonDerivative · entry 3

Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,357

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $22.13 to $23.11, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 22:33 UTC
Bizily ScottChief Legal and HR Officer
SaleCommon Stock 400 $21.52 $8,606.00
Disclosure

SEC source: 0001567619-22-021291 · doc1.xml · nonDerivative · entry 2

Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,332

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $20.92 to $21.79, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 22:33 UTC
Bizily ScottChief Legal and HR Officer
Exercise / conversionCommon Stock 1,875 $6.49 $12,168.75
Disclosure

SEC source: 0001567619-22-021291 · doc1.xml · nonDerivative · entry 1

Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F9 · balance_after: Reflects 2,857 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.

Read SEC document
September 23, 2022 Filed Sep 27, 2022 17:08 UTC GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $8.06 $0.00
Disclosure

SEC source: 0001567619-22-017850 · doc1.xml · derivative · entry 1

Kasahara Noriyuki · CIK 0001943840 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2032-09-22

F1 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on September 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on September 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).

Read SEC document
September 23, 2022 Filed Sep 27, 2022 21:05 UTC
Kamal FariborzPresident & COO
GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $8.06 $0.00
Disclosure

SEC source: 0001567619-22-017847 · doc1.xml · derivative · entry 1

Kamal Fariborz · CIK 0001834020 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2032-09-22

F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 23, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.

Read SEC document
September 01, 2022 Filed Sep 7, 2022 00:38 UTC
Bizily ScottChief Legal and HR Officer
GrantStock Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $8.04 $0.00
Disclosure

SEC source: 0001567619-22-017098 · doc1.xml · derivative · entry 1

Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2032-08-31

F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.

Read SEC document
September 01, 2022 Filed Sep 6, 2022 20:42 UTC
FISHMAN ROBERT SChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $8.04 $0.00
Disclosure

SEC source: 0001567619-22-017102 · doc1.xml · derivative · entry 1

FISHMAN ROBERT S · CIK 0001232237 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2032-08-31

F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.

Read SEC document
September 01, 2022 Filed Sep 7, 2022 00:41 UTC
Moretti August JChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $8.04 $0.00
Disclosure

SEC source: 0001567619-22-017101 · doc1.xml · derivative · entry 2

Moretti August J · CIK 0001344412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2032-08-31

F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.

Read SEC document
September 01, 2022 Filed Sep 7, 2022 00:40 UTC
Kamal FariborzSee Remarks
GrantStock Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $8.04 $0.00
Disclosure

SEC source: 0001567619-22-017099 · doc1.xml · derivative · entry 1

Kamal Fariborz · CIK 0001834020 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2032-08-31

F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.

Read SEC document
June 18, 2022 Filed Jun 21, 2022 23:54 UTC
Bizily ScottChief Legal and HR Officer
GrantStock Option (Right to Buy) · Derivative 24,000 $0.00 Strike: $6.49 $0.00
Disclosure

SEC source: 0001567619-22-013209 · doc1.xml · derivative · entry 1

Bizily Scott · CIK 0001920738 · Chief Legal and HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2032-06-17

F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of June 16, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.

Read SEC document
May 23, 2022 Filed May 25, 2022 23:00 UTC
Chacko JacobDirector
GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001567619-22-011718 · doc1.xml · derivative · entry 1

Chacko Jacob · CIK 0001608936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2032-05-22

F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).

Read SEC document
May 23, 2022 Filed May 25, 2022 23:05 UTC GrantStock Option (Right to Buy) · Derivative 33,750 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001567619-22-011721 · doc1.xml · derivative · entry 1

MILLIGAN JOHN F · CIK 0001191589 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,750

Underlying: Common Stock · 33,750 shares

Expires 2032-05-22

F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).

Read SEC document
May 23, 2022 Filed May 25, 2022 23:08 UTC GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001567619-22-011723 · doc1.xml · derivative · entry 1

Tomasello Shawn · CIK 0001617239 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2032-05-22

F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).

Read SEC document
May 23, 2022 Filed May 25, 2022 23:06 UTC GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001567619-22-011722 · doc1.xml · derivative · entry 1

THEUER CHARLES · CIK 0001631338 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2032-05-22

F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).

Read SEC document
May 23, 2022 Filed May 25, 2022 23:01 UTC GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001567619-22-011719 · doc1.xml · derivative · entry 1

GRAY SUSANNAH · CIK 0001833453 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2032-05-22

F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).

Read SEC document
May 23, 2022 Filed May 25, 2022 23:02 UTC GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0001567619-22-011720 · doc1.xml · derivative · entry 1

Miller-Rich Nancy · CIK 0001735084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2032-05-22

F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).

Read SEC document
February 01, 2022 Filed Feb 3, 2022 17:42 UTC
Zimmermann CarolyneChief Business Officer
GrantStock Option (Right to Buy) · Derivative 35,000 $0.00 Strike: $15.78 $0.00
Disclosure

SEC source: 0001567619-22-002467 · doc1.xml · derivative · entry 1

Zimmermann Carolyne · CIK 0001860163 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2032-01-31

F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 17:39 UTC
FISHMAN ROBERT SChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 65,000 $0.00 Strike: $15.78 $0.00
Disclosure

SEC source: 0001567619-22-002464 · doc1.xml · derivative · entry 1

FISHMAN ROBERT S · CIK 0001232237 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2032-01-31

F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 22:43 UTC
Moretti August JChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 65,000 $0.00 Strike: $15.78 $0.00
Disclosure

SEC source: 0001567619-22-002468 · doc1.xml · derivative · entry 2

Moretti August J · CIK 0001344412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2032-01-31

F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 22:40 UTC
Kirn DavidDirector · Chief Executive Officer · 10% owner
GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $15.78 $0.00
Disclosure

SEC source: 0001567619-22-002466 · doc1.xml · derivative · entry 2

Kirn David · CIK 0001834021 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2032-01-31

F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 22:39 UTC
Kamal FariborzSee Remarks
GrantStock Option (Right to Buy) · Derivative 70,000 $0.00 Strike: $15.78 $0.00
Disclosure

SEC source: 0001567619-22-002465 · doc1.xml · derivative · entry 1

Kamal Fariborz · CIK 0001834020 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2032-01-31

F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company.

Read SEC document
October 22, 2021 Filed Oct 22, 2021 21:42 UTC SaleCommon Stock 1,900 $31.00 $58,892.78
Disclosure

SEC source: 0001567619-21-018628 · doc1.xml · nonDerivative · entry 3

SCHAFFER DAVID · CIK 0001692929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 901,215

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The transaction was executed in multiple trades in prices ranging from $30.76 to $31.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 21, 2021 Filed Oct 22, 2021 21:42 UTC SaleCommon Stock 22,820 $31.56 $720,155.84
Disclosure

SEC source: 0001567619-21-018628 · doc1.xml · nonDerivative · entry 2

SCHAFFER DAVID · CIK 0001692929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 903,115

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $30.70 to $32.39, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 20, 2021 Filed Oct 22, 2021 21:42 UTC SaleCommon Stock 11,565 $31.02 $358,770.59
Disclosure

SEC source: 0001567619-21-018628 · doc1.xml · nonDerivative · entry 1

SCHAFFER DAVID · CIK 0001692929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 925,935

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $30.27 to $32.07,inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 30, 2021 Filed Oct 1, 2021 16:34 UTC SaleCommon Stock 4,549 $27.28 $124,084.89
Disclosure

SEC source: 0001567619-21-017751 · doc1.xml · nonDerivative · entry 5

SCHAFFER DAVID · CIK 0001692929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 937,500

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F6 · price: The transaction was executed in multiple trades in prices ranging from $27.08 to $27.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 30, 2021 Filed Oct 1, 2021 16:34 UTC SaleCommon Stock 7,836 $26.69 $209,164.78
Disclosure

SEC source: 0001567619-21-017751 · doc1.xml · nonDerivative · entry 4

SCHAFFER DAVID · CIK 0001692929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 942,049

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The transaction was executed in multiple trades in prices ranging from $26.07 to $27.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 29, 2021 Filed Oct 1, 2021 16:34 UTC SaleCommon Stock 700 $30.06 $21,044.17
Disclosure

SEC source: 0001567619-21-017751 · doc1.xml · nonDerivative · entry 3

SCHAFFER DAVID · CIK 0001692929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 949,885

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The transaction was executed in multiple trades in prices ranging from $29.75 to $30.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 29, 2021 Filed Oct 1, 2021 16:34 UTC SaleCommon Stock 8,365 $29.06 $243,057.62
Disclosure

SEC source: 0001567619-21-017751 · doc1.xml · nonDerivative · entry 2

SCHAFFER DAVID · CIK 0001692929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 950,585

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $28.71 to $29.69, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 29, 2021 Filed Oct 1, 2021 16:34 UTC SaleCommon Stock 7,806 $27.99 $218,511.80
Disclosure

SEC source: 0001567619-21-017751 · doc1.xml · nonDerivative · entry 1

SCHAFFER DAVID · CIK 0001692929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 958,950

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $27.70 to $28.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 28, 2021 Filed Sep 29, 2021 16:05 UTC SaleCommon Stock 100 $32.00 $3,200.00
Disclosure

SEC source: 0001567619-21-017624 · doc1.xml · nonDerivative · entry 5

SCHAFFER DAVID · CIK 0001692929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 966,756

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
September 28, 2021 Filed Sep 29, 2021 16:05 UTC SaleCommon Stock 13,812 $30.52 $421,492.52
Disclosure

SEC source: 0001567619-21-017624 · doc1.xml · nonDerivative · entry 4

SCHAFFER DAVID · CIK 0001692929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 966,856

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The transaction was executed in multiple trades in prices ranging from $30.28 to $31.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 27, 2021 Filed Sep 29, 2021 16:05 UTC SaleCommon Stock 100 $34.19 $3,419.00
Disclosure

SEC source: 0001567619-21-017624 · doc1.xml · nonDerivative · entry 3

SCHAFFER DAVID · CIK 0001692929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 980,668

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
September 27, 2021 Filed Sep 29, 2021 16:05 UTC SaleCommon Stock 6,157 $33.51 $206,330.31
Disclosure

SEC source: 0001567619-21-017624 · doc1.xml · nonDerivative · entry 2

SCHAFFER DAVID · CIK 0001692929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 980,768

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The transaction was executed in multiple trades in prices ranging from $33.10 to $34.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 27, 2021 Filed Sep 29, 2021 16:05 UTC SaleCommon Stock 13,075 $32.59 $426,076.33
Disclosure

SEC source: 0001567619-21-017624 · doc1.xml · nonDerivative · entry 1

SCHAFFER DAVID · CIK 0001692929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 986,925

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $32.09 to $33.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3 · balance_after: Since the date of the reporting person's last ownership report, he transferred 1,000,000 shares of FDMT common stock to his ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse.

Read SEC document
June 07, 2021 Filed Jun 9, 2021 20:28 UTC
Zimmermann CarolyneChief Business Officer
GrantStock Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $26.83 $0.00
Disclosure

SEC source: 0001567619-21-011946 · doc1.xml · derivative · entry 1

Zimmermann Carolyne · CIK 0001860163 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2031-06-06

F1 · derivative.exercise_date: The stock option will vest with respect to 25% of the total number of the underlying shares on June 7, 2022, and the remaining shares will vest in equal monthly installments over the following three-year period, such that the stock option will be fully vested on June 7, 2025, subject to the Reporting Person continuing to be a service provider to Issuer through each vesting date.

Read SEC document
May 17, 2021 Filed May 19, 2021 20:34 UTC GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $26.89 $0.00
Disclosure

SEC source: 0001567619-21-010750 · doc1.xml · derivative · entry 1

SCHAFFER DAVID · CIK 0001692929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2031-05-16

F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).

Read SEC document
May 17, 2021 Filed May 20, 2021 00:33 UTC
Chacko JacobDirector
GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $26.89 $0.00
Disclosure

SEC source: 0001567619-21-010749 · doc1.xml · derivative · entry 1

Chacko Jacob · CIK 0001608936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2031-05-16

F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).

Read SEC document
May 17, 2021 Filed May 20, 2021 00:33 UTC GrantStock Option (Right to Buy) · Derivative 11,250 $0.00 Strike: $26.89 $0.00
Disclosure

SEC source: 0001567619-21-010748 · doc1.xml · derivative · entry 2

MILLIGAN JOHN F · CIK 0001191589 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,250

Underlying: Common Stock · 11,250 shares

Expires 2031-05-16

F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).

Read SEC document
May 17, 2021 Filed May 20, 2021 00:33 UTC GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $26.89 $0.00
Disclosure

SEC source: 0001567619-21-010748 · doc1.xml · derivative · entry 1

MILLIGAN JOHN F · CIK 0001191589 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2031-05-16

F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).

Read SEC document
May 17, 2021 Filed May 20, 2021 00:31 UTC GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $26.89 $0.00
Disclosure

SEC source: 0001567619-21-010746 · doc1.xml · derivative · entry 1

Tomasello Shawn · CIK 0001617239 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2031-05-16

F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).

Read SEC document
May 17, 2021 Filed May 20, 2021 00:36 UTC GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $26.89 $0.00
Disclosure

SEC source: 0001567619-21-010751 · doc1.xml · derivative · entry 1

THEUER CHARLES · CIK 0001631338 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2031-05-16

F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).

Read SEC document
May 17, 2021 Filed May 20, 2021 00:32 UTC GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $26.89 $0.00
Disclosure

SEC source: 0001567619-21-010747 · doc1.xml · derivative · entry 1

Miller-Rich Nancy · CIK 0001735084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2031-05-16

F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).

Read SEC document
May 17, 2021 Filed May 20, 2021 00:30 UTC GrantStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $26.89 $0.00
Disclosure

SEC source: 0001567619-21-010745 · doc1.xml · derivative · entry 1

GRAY SUSANNAH · CIK 0001833453 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2031-05-16

F1 · shares: Automatically granted pursuant to the terms of the Company's non-employee director compensation program.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).

Read SEC document
April 12, 2021 Filed Apr 14, 2021 20:32 UTC
Moretti August JChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,000 $0.00 Strike: $9.41 $0.00
Disclosure

SEC source: 0001567619-21-008045 · doc1.xml · derivative · entry 2

Moretti August J · CIK 0001344412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 223,060

Underlying: Common Stock · 1,000 shares

Expires 2029-03-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option is partially vested and will vest with respect to the remaining shares in equal monthly installments until fully vested on January 7, 2023.

Read SEC document
April 12, 2021 Filed Apr 14, 2021 20:32 UTC
Moretti August JChief Financial Officer
Exercise / conversionCommon Stock 1,000 $9.41 $9,410.00
Disclosure

SEC source: 0001567619-21-008045 · doc1.xml · nonDerivative · entry 1

Moretti August J · CIK 0001344412 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 08, 2021 Filed Mar 10, 2021 21:04 UTC
Moretti August JSee Remarks
GrantStock Option (Right to Buy) · Derivative 70,000 $0.00 Strike: $41.66 $0.00
Disclosure

SEC source: 0001567619-21-005966 · doc1.xml · derivative · entry 1

Moretti August J · CIK 0001344412 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2031-03-07

F1 · derivative.exercise_date: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 8, 2021 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.